Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer's disease? An overview of research evidence in the elderly patient population

Alzheimer's disease (AD) is a neurodegenerative disease, in which an accumulation of toxic amyloid beta in the brain precedes the emergence of clinical symptoms. AD spectrum consists of presymptomatic, early symptomatic, and symptomatic phase of dementia. At present, no pharmacotherapy exists t...

Descripción completa

Detalles Bibliográficos
Autor principal: Rygiel, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105210/
https://www.ncbi.nlm.nih.gov/pubmed/27763482
http://dx.doi.org/10.4103/0022-3859.188553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105210/
https://www.ncbi.nlm.nih.gov/pubmed/27763482
http://dx.doi.org/10.4103/0022-3859.188553

Ejemplares similares